Evidence map›Paper›PMID 35053261›Full record

ArticleBiomolecules2022

Functional and Kinetic Comparison of Alanine Cysteine Serine Transporters ASCT1 and ASCT2.

Jiali Wang, Yang Dong, Christof Grewer

Open access · goldAbstract read
In one paragraph

Article in Biomolecules, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.6field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Targeting glutamine metabolism as a potential target for cancer treatment.Journal of experimental & clinical cancer research : CR · 2025
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Jiali WangDepartment of Chemistry, Binghamton University, 4400 Vestal Parkway East, Binghamton, NY 13902, USA.ORCID 0000-0002-9520-8140
Yang DongDepartment of Chemistry, Binghamton University, 4400 Vestal Parkway East, Binghamton, NY 13902, USA.
Christof GrewerDepartment of Chemistry, Binghamton University, 4400 Vestal Parkway East, Binghamton, NY 13902, USA.
Binghamton University · US

Funding

Substrate Specificity Determinants in Nutrient Solute Carrier TransportersR01GM108911 · NIGMS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI SCHLESSINGER, AVNER · 2014 to 2022
$3.1M
How to Combat Glutamate Release by Reverse Transport: Mechanistic Studies and Development of Selective Efflux InhibitorsR15GM135843 · NIGMS · STATE UNIVERSITY OF NY,BINGHAMTON · PI GREWER, CHRISTOF THEODOR · 2019 to 2019
$450k
NIGMS NIH HHS R01 GM108911NIGMS NIH HHS R15 GM135843
6 · The paper itself

Abstract

Neutral amino acid transporters ASCT1 and ASCT2 are two SLC1 (solute carrier 1) family subtypes, which are specific for neutral amino acids. The other members of the SLC1 family are acidic amino acid transporters (EAATs 1-5). While the functional similarities and differences between the EAATs have been well studied, less is known about how the subtypes ASCT1 and 2 differ in kinetics and function. Here, by performing comprehensive electrophysiological analysis, we identified similarities and differences between these subtypes, as well as novel functional properties, such as apparent substrate affinities of the inward-facing conformation (in the range of 70 μM for L-serine as the substrate). Key findings were: ASCT1 has a higher apparent affinity for Na

Indexed as

Amino Acid Transport System ASCSerineAlanineCysteineKineticsAlanineAmino Acid Transport System ASCCysteineSerineelectrophysiologykineticsneutral amino acid transporterrapid solution exchange

Identifiers

PMID35053261
PMCPMC8773628
OpenAlexW4206274146

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.